If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cost reductions;delay to Ann. Report;New contract

5 Jun 2023 07:00

RNS Number : 5720B
Deepverge PLC
05 June 2023
 

5 June 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company" or "the Group")

 

Further cost reductions; Possible delay to publication of Annual Report and Accounts; New £2.3m, four-year contract

 

DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces that: (i) it will be downsizing its Labskin, Skin Trust Club and Rinocloud business units as part of further measures to improve the financial position of the Group; (ii) it is possible that it will need to delay the announcement of its results for the year ended 31 December 2022 and publication of its Annual Report and Accounts for the same period; (iii) it is continuing to carefully manage its working capital position and to seek new financing opportunities and also consider the potential sale of one or more lines of its business; and (iv) it is pleased to announce a new manufacturing contract win. 

Downsizing of the Labskin, Skin Trust Club and Rinocloud business units

The Company's financial position is such that the Board has taken the decision to no longer support the ongoing costs of progressing the development of the Labskin, Skin Trust Club and associated elements of the Rinocloud businesses, whilst retaining the capacity required to continue supporting the Modern Water and Glanaco businesses. The Company is therefore downsizing these business units, with effect from 1 July 2023, which will involve the elimination of approximately twenty permanent employee and contract positions. A programme is now in progress to ensure an orderly downsizing process is conducted.  The Company remains proud of the patents and databases that have been developed to date and continues to explore out-licensing opportunities of this technology with companies engaged in the life-sciences industry.

Possibility of delay to the announcement of the results for the year ended 31 December 2022 and publication of the Annual Report

The possibility of delay is caused, inter alia, by the resignation of the Group's previous auditor, Jeffreys Henry LLP, as announced on 24 March 2023. Following a change of ownership and name, Jeffreys Henry LLP undertook a review of its capacity to undertake audit work, in conjunction with the Institute of Chartered Accountants in England and Wales which concluded that the firm did not have sufficient capacity to satisfy its regulatory requirements and as a result resigned as auditor to a number of quoted companies, including DeepVerge.

 

The resignation of Jeffreys Henry occurred just days before the audit of DeepVerge's accounts was due to start. Haysmacintyre LLP was subsequently appointed as the Company's auditor, however there is significant risk of there being insufficient time to ensure that the audit is completed by 30 June 2023.

If the Company is unable to publish its Annual Report and Accounts by 30 June 2023 in accordance with AIM Rule 19, then the trading in the Company's ordinary shares on AIM would be suspended from 7.30am on Monday 3 July 2023 until such Annual Report is published. Any such delay would be likely to be limited to a matter of weeks.

New Funding opportunities and potential sale of parts of the business

The Company announced (RNSs of 17 and 19 April 2023) that due to the phasing and timing of contract cashflows it was operating from a limited working capital position. The Company continues to explore a number of financing options including the raising of equity, debt or trade finance to improve the Group's financial position. The Company is also exploring the potential sale of one or more lines of business.

New Manufacturing Contract in Ireland

The Company is pleased to announce that its subsidiary, Glanaco Ltd., has won a new contract for the supply of customised environmental cleaning and monitoring equipment to an undisclosed customer within the EU. Under the terms of the deal the Company will lease this equipment to the customer across a four-year period commencing in the second half of 2023.

The overall revenue will amount to approximately £2.3 million and will be recognised across the coming four years.

Further updates will be given as appropriate.

 

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSLFLLEDSEDM
Date   Source Headline
1st Feb 20218:30 amRNSAppointment of former IBM Legal Counsel as CoSec
1st Feb 20217:00 amRNSAppointment of former IBM Legal Counsel as CoSec
25th Jan 20212:22 pmRNSExercise of Warrants and Total Voting Rights
18th Jan 20214:51 pmRNSExercise of Options and Total Voting Rights
15th Jan 20217:00 amRNSCompletion of Compulsory Acquisition; TVR
11th Jan 20217:00 amRNSDVRG confirms maiden Q4 profit;guides £10m in 2021
11th Dec 20207:00 amRNSNew Labskin service - update
3rd Dec 20204:26 pmRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSTrading Update & Investor Presentation
27th Nov 20207:00 amRNSInterim analysis from Aberdeen Uni - Labskin study
25th Nov 20207:00 amRNSInvestor presentation and corporate update
23rd Nov 20209:26 amRNSHolding(s) in Company
19th Nov 20205:25 pmRNSIssue of Share Options/PDMR Dealings
18th Nov 202012:17 pmRNSTR-1: Notification of major holdings
18th Nov 202011:06 amRNSSecond Price Monitoring Extn
18th Nov 202011:00 amRNSPrice Monitoring Extension
17th Nov 20203:43 pmRNSDirector/PDMR Shareholding
17th Nov 20203:38 pmRNSAllotment of Shares Following Close of Offer
16th Nov 20207:00 amRNSUpdate on detection products
13th Nov 20205:22 pmRNSHolding(s) in Company
10th Nov 20202:57 pmRNSExercise of Warrants and Total Voting Rights
10th Nov 20201:14 pmRNSExchange and Grant of Options and Warrants
10th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20205:30 pmRNSDeepverge
9th Nov 20205:02 pmRNSAllotment of Shares and Level of Acceptances
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 20208:46 amRNSHolding(s) in Company
9th Nov 20208:06 amRNSOffer Unconditional in all respects
3rd Nov 20203:00 pmRNSOFFER UNCONDITIONAL AS TO ACCEPTANCES; EXTENDED
26th Oct 20206:31 pmRNSForm 8.3 - Deepverge PLC
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
23rd Oct 20204:08 pmRNSComment on detection of COVID-19 in UK Sewage
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20209:05 amRNSSecond Price Monitoring Extn
22nd Oct 20209:00 amRNSPrice Monitoring Extension
13th Oct 20203:55 pmRNSPublication of Offer Document; Rule 15 letters
13th Oct 20203:45 pmRNSReplacement - Form 8 (OPD) - Modern Water plc
9th Oct 20207:00 amRNSUpdate on Offer for Modern Water plc by DeepVerge
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
7th Oct 202011:05 amRNSSecond Price Monitoring Extn
7th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20209:05 amRNSSecond Price Monitoring Extn
7th Oct 20209:00 amRNSPrice Monitoring Extension
6th Oct 20205:21 pmRNSForm 8.3 -Deepverge PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.